-
Featured
Advanced Technology Improves Cervical Spine Surgery Outcomes
Surgeons in Massachusetts General Hospital's Neurosurgical Spine Service use a multidisciplinary approach to treat cervical spine deformities with complex surgeries using innovative technology including artificial intelligence.
-
Featured
Finding New Approaches to Treat Desmoid Tumor Patients
Surgery for desmoid tumors is only about 50% effective. Multidisciplinary care may be more effective for helping patients find relief.
-
Metastatic Patterns Vary Substantially Between Subtypes of Soft Tissue Sarcoma
Marcos R. Gonzalez, MD, Santiago A. Lozano-Calderon, MD, PhD, and colleagues found metastatic patterns differ widely between subtypes of soft tissue sarcomas in the extremities and pelvis, underscoring the need for subtype-specific management strategies. Even with (neo)-adjuvant treatment, prognosis was dismal.
-
Web Tool Predicts Six-Week Survival After Spinal Metastasis Treatment With Surgery or Radiation
Based on a study of 4,304 patients from five institutions, Aditya Karhade, MD, MBA, Joseph Schwab, MD, MS, and colleagues developed and externally validated a model for predicting six-week mortality after surgery or radiation therapy for spinal metastases. It's been incorporated into an open-access web calculator.
-
Adding High-Dose Radiation to Surgery Confers Survival Benefit in Patients With Chordoma
Daniel G. Tobert, MD, Joseph H. Schwab, MD, MS, and colleagues demonstrated that adding photon and/or proton radiation therapy (≥70 Gy) to surgical excision of chordoma was associated with 72% less risk of death and 77% less risk of local recurrence within five years.
-
Estimating the Survival of Patients With Spinal Metastasis
Using an online survey, Quirina Thio, Joseph Schwab, MD, and colleagues documented poor agreement between surgeons who were asked to estimate survival for 12 patients with spinal metastasis. There was also a substantial discrepancy between the surgeons' estimates and the patients' actual survival.
Mass General Cancer Center Contributors
-
Erik T. Newman, MD
Orthopaedic Oncology Surgeon, Department of Orthopaedics, Massachusetts General Hospital, Instructor in Orthopaedic Surgery, Harvard Medical School
Recent Article
Minimal Clinically Important Differences for Lower Extremity Metastatic Surgery -
John H. Shin, MD
Director, Spinal Deformity and Spine Oncology (Mass General Cancer Center), Spinal Reconstruction Surgery
Recent Article
Clinical Advances in Minimally Invasive Spinal Neurosurgery
-
Kevin Andrew Raskin, MD
Chief, Orthopaedic Oncology Service, Program Director, Musculoskeletal Oncology Fellowship Program, Massachusetts General Hospital, Assistant Professor of Orthopaedic Surgery, Harvard Medical School
Recent Article
Nutritional, Physiological Factors Affect Wound Infection After Surgery for Lower-Extremity Soft Tissue Sarcoma
-
Santiago A. Lozano-Calderon, MD, PhD
Orthopaedic Oncology Surgeon, Assistant Professor, Orthopaedic Surgery, Harvard Medical School
Recent Article
Metastatic Patterns Vary Substantially Between Subtypes of Soft Tissue Sarcoma
Orthopaedic Oncology Service at Mass General
As members of the Cancer Center at Massachusetts General Hospital, the Orthopaedic Oncology team provides compassionate care to children, adolescents and adults with primary bone and soft tissue tumors (benign and malignant) and metastatic.
